SCHEMBL7950773

SCHEMBL7950773

CCCCn1cnc(C(=O)OCC)c1N

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
ALDH1A1 P00352 4/20 0.41
ADORA2A P29274 2/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA1 P30542 1/20 0.41
MAPT P10636 1/20 0.41
TNF P01375 2/20 0.40
KDM4E B2RXH2 3/20 0.40
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28685543 0.94 ALDH1A1 (0.43) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL28688774 0.94 ALDH1A1 (0.43) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL28702918 0.94 ALDH1A1 (0.43) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL28679499 0.94 ALDH1A1 (0.43) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL28688772 0.94 ALDH1A1 (0.43) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL3174463 0.91 ALDH1A1 (0.43) NPC1RAB9ASMN1; SMN2ALDH1A1ADORA2A
SCHEMBL1992837 0.85 ALDH1A1 (0.45) NPC1RAB9ASMN1; SMN2ALDH1A1ADORA2A
SCHEMBL7951572 0.83 ALDH1A1 (0.41) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL3465048 0.82 ALDH1A1 (0.49) ALDH1A1ADORA2AMAPTKDM4ELMNA
SCHEMBL1990691 0.80 ALDH1A1 (0.46) NPC1RAB9ASMN1; SMN2ALDH1A1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6174906-B1 TREATMENT OF DISEASES CAUSED BY AN EXCESS OF ENDOTHELIN COMPRISING ADMINISTERING ENDOTHELIN RECEPTOR ANTAGONIST COMPOUND; FOR TREATING UNSTABLE ANGINA, CORONARY VASOSPASM AND MYOCARDIAL SALVAGE, RESTENOSIS, PULMONARY HYPERTENSION SMITHKLINE BEECHAM CORPORATION 2001-01-16 US disclosed
US-6030970-A TREATING RENAL FAILURE OR CEREBROVASCULAR DISEASE, RADIO-CONTRAST INDUCED RENAL FAILURE, CONGESTIVE HEART FAILURE, UNSTABLE ANGINA, CORONARY VASOPASM, MYOCARDIAL SALVAGE, RESTENOSIS, PULMONARY HYPERTENSION, STROKES SMITHKLINE BEECHAM CORPORATION (US) 2000-02-29 US disclosed
EP-0841926-A4 ENDOTHELIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 1999-08-04 EP disclosed
EP-0841926-A1 ENDOTHELIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1998-05-20 EP disclosed
WO-1997004774-A1 ENDOTHELIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1997-02-13 WO disclosed